Among the downstream signaling pathways activated by BCR/ABL tyrosine kinase, the abnormal activation of mitogen-activated protein kinase (MAPK) pathway plays an important role in the occurrence and development of CML [8, 9]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.